Literature DB >> 25178520

Personality disorder moderates outcome in short- and long-term group analytic psychotherapy: A randomized clinical trial.

Steinar Lorentzen1, Torleif Ruud, Anette Fjeldstad, Per A Høglend.   

Abstract

OBJECTIVES: In a randomized clinical trial, short- and long-term psychodynamic group psychotherapy (STG and LTG, respectively) schedules were equally effective for the 'typical' patient during a 3-year study period. Although several studies have reported good effects for patients with personality disorders (PD) in diverse forms of psychotherapy, the significance of treatment duration is unclear. Therefore, we tested the hypothesis that PD patients would improve more during and after LTG than STG.
DESIGN: A randomized, longitudinal, prospective study contrasting the outcomes during and after short- and long-term dynamic group psychotherapies.
METHODS: One hundred and sixty-seven outpatients with mood disorders, anxiety disorders, or PD were randomized to STG or LTG (respectively, 20 or 80 weekly sessions of 90 min each). Outcome measures are as follows: symptoms (SCL-90-R), interpersonal problems (IIP-C), and psychosocial functioning (GAF split version: GAF-Symptom and GAF-Function). PD pathology (number of PD criteria items) was selected a priori as a putative moderator of treatment effects. Change during the 3-year study period was assessed using linear mixed models. The study was registered at ClinicalTrials.gov as NCT 00021417.
RESULTS: Our hypothesis was supported, as patients with PD improved significantly more regarding all outcome variables in LTG than STG. For patients without PD, the rate of change was similar across 3 years; however, the rate of change in symptoms and interpersonal problems was higher in STG during the first 6 months.
CONCLUSIONS: The effectiveness of LTG is higher for patients with co-morbid PD. Patients without PD do not appear to experience additional gain from LTG. PRACTITIONER POINTS: Clinical implications: LTG demonstrates better effectiveness than STG for patients with personality disorder co-morbidity (PD). Patients without PD do not appear to experience additional gain from attending LTG. Correct initial allocation to treatment duration may prevent disruptive breaks in relationships and lead to both human and economic cost savings. Limitations: Trials on mixed diagnostic samples may limit the ability to fully assess change for specific diagnostic groups. Therapists were unable to select patients and compose their own groups. Although this condition might increase the generalizability of the results, it may also have restricted the therapists and the clinical situation inadvertently.
© 2014 The British Psychological Society.

Entities:  

Keywords:  Group analytic psychotherapy; RCT; group; personality disorder; short-term and long-term

Mesh:

Year:  2014        PMID: 25178520     DOI: 10.1111/bjc.12065

Source DB:  PubMed          Journal:  Br J Clin Psychol        ISSN: 0144-6657


  4 in total

1.  Psychological interventions for antisocial personality disorder.

Authors:  Simon Gibbon; Najat R Khalifa; Natalie H-Y Cheung; Birgit A Völlm; Lucy McCarthy
Journal:  Cochrane Database Syst Rev       Date:  2020-09-03

2.  Psychological therapies for people with borderline personality disorder.

Authors:  Ole Jakob Storebø; Jutta M Stoffers-Winterling; Birgit A Völlm; Mickey T Kongerslev; Jessica T Mattivi; Mie S Jørgensen; Erlend Faltinsen; Adnan Todorovac; Christian P Sales; Henriette E Callesen; Klaus Lieb; Erik Simonsen
Journal:  Cochrane Database Syst Rev       Date:  2020-05-04

3.  Impact of dissociation on treatment of depressive and anxiety spectrum disorders with and without personality disorders.

Authors:  Jan Prasko; Ales Grambal; Petra Kasalova; Dana Kamardova; Marie Ociskova; Michaela Holubova; Kristyna Vrbova; Zuzana Sigmundova; Klara Latalova; Milos Slepecky; Marta Zatkova
Journal:  Neuropsychiatr Dis Treat       Date:  2016-10-17       Impact factor: 2.570

4.  Focused group analytic psychotherapy: An integration of clinical experience and research.

Authors:  Steinar Lorentzen
Journal:  J Clin Psychol       Date:  2022-06-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.